1 No-Brainer Nuclear Stock to Buy With $2,000 Right Now

Fluor Corporation (NYSE: FLR) owns 38.9% of NuScale (implied NuScale market cap ~$6.0B, Fluor stake ~ $2.3B) and has roughly $1.8B more cash than debt, supporting ~62% of its $6.6B market capitalization and leaving an effective enterprise value near $2.5B. Fluor reported $3.4B in LTM earnings that were largely driven by an accounting gain tied to NuScale, but analysts project roughly $360M in “real” profit next year with ~12% annual earnings growth, implying an EV/earnings multiple below 7 on modeled results. Geopolitical trade developments — including a reported Japanese commitment to finance $80B for 10 large U.S. nuclear plants as part of a $550B investment/tariff-relief arrangement — could boost Fluor’s core large-reactor construction franchise even as SMR peers remain unprofitable.

Analysis

Market structure: The immediate winners are large EPC/engineering contractors (FLR) and suppliers of heavy materials (steel, concrete, transformers) because announced capital (Japan $80B for 10 large plants) reallocates demand to gigawatt-scale builds rather than near-term SMRs. Pure-play SMR developers (SMR, NNE, OKLO) and their early equity holders are the losers as markets increasingly price in long commercialization timelines and dilution; this shifts pricing power to established contractors with backlog and balance sheets that can absorb multiyear cash intensity. Cross-asset signals: longer project durations increase interest-rate sensitivity for utilities and lenders, likely flattening credit spreads for leveraged EPCs if project finance is secured; commodity nodes (rebar, copper, uranium) should see upward pressure over 12–36 months while SMR option volatility stays elevated.

Risk assessment: Tail risks include large cost overruns or a major regulatory setback that could wipe out multi-year margins (analogous to 2010s reactor projects); a nuclear incident or rapid rate shock would materially re-rate long-dated cash flows. Time horizons diverge: days–weeks = headline risk (DOE/Japan updates, quarterly prints), months = contract awards and stake sales, years = plant builds and SMR commercialization (2030+). Hidden dependencies: FLR’s reported earnings have been boosted by NuScale mark-to-market gains and stake sales — monitor sticking points such as remaining stake %, earn-outs and contingent liabilities. Catalysts: US DOE/contract awards, Japan fund tranche releases, and FLR quarterly backlog disclosures can accelerate re-rating within 3–12 months.

Trade implications: Direct play — establish a tactical 2–3% long position in FLR (NYSE: FLR) over 4–12 weeks to capture potential re-rating from large-reactor contracts while funding optionality from the NuScale stake; tighten position if FLR/EV-to-next-year earnings rises above 10x or stock returns +30%. Relative-value — pair trade long FLR vs short NuScale (SMR) sized to be dollar-neutral: expect SMR downside while FLR benefits from large plant demand; target 6–12 month horizon. Options — buy 12–18 month FLR LEAP calls ~20% OTM (size 30% of underlying position) and fund with 3–6 month put spreads on SMR (buy 25%–10% OTM) to asymmetrically capture upside and cap short-side cost. Sector rotation — trim pure-play SMR speculative exposure (NNE, OKLO) by 50% within 30 days and reallocate proceeds to industrials/EPC stocks and selective uranium miners.

Contrarian angles: The market underestimates persistence of gigawatt nuclear demand; consensus prizes SMRs as the only growth vector but ignores the immediate $80B+ tendering opportunity favoring incumbents. The sell-off in SMR equities may be overdone on a 6–24 month view if developers demonstrate anchor customers, but investors underprice execution risk — history (Westinghouse/CB&I) shows overruns can destroy equity. Unintended consequences: a rapid pivot back to large reactors could create supply bottlenecks that inflate input costs and compress margins for anyone without secured supply chains; set re-eval triggers: add to FLR if EV/next-year EBITDA falls below 6x or if FLR wins ≥$1bn of new contracts in a quarter, and cut exposure if NuScale’s market cap surpasses $8bn without commensurate revenue recognition.

Key Decisions for Investors

• Establish a tactical 2–3% long position in Fluor (FLR) over the next 4–12 weeks to capture re-rating from large-reactor contracts; size to risk budget, add another 1–2% only if FLR reports ≥$1bn in new nuclear backlog or EV/next-year earnings drops below 6x.
• Implement a dollar-neutral pair trade: go long FLR (2% portfolio) and short NuScale (SMR) equal-dollar (1–1.5% portfolio) targeting a 6–12 month horizon; unwind if SMR falls >40% or FLR rises >30%.
• Buy asymmetric options: purchase 12–18 month FLR LEAP calls ~20% OTM sized at 30% of the cash position and fund by selling/rolling short-dated covered calls or buying 3–6 month bear put spreads on SMR (e.g., buy 25% OTM put, sell 10% OTM put) to limit cost and capture SMR downside.
• Trim speculative exposure to NNE and OKLO by ~50% within 30 days unless management delivers clear commercial contracts/revenue guidance for 2026; reallocate proceeds to industrials/EPC names and selective uranium exposure (miners) with strong balance sheets.
• Monitor three specific catalysts over the next 90 days before scaling positions: (1) FLR quarterly backlog/award announcements, (2) US DOE or Japan tranche disbursement timing for the $80B program, and (3) changes to FLR’s remaining NuScale stake (%) and any realized stake-sale proceeds.